|
US3314941A
(en)
*
|
1964-06-23 |
1967-04-18 |
American Cyanamid Co |
Novel substituted pyridodiazepins
|
|
DE1645976A1
(de)
|
1966-06-18 |
1971-01-21 |
Ajinomoto Kk |
Verfahren zur Herstellung von Adenosin und 2',3'-O-Isopropylidenadenosin
|
|
ZA704419B
(en)
|
1969-07-21 |
1971-04-28 |
Ici Australia Ltd |
Injectable aqueous solutions of tetramisole
|
|
US3692907A
(en)
|
1970-10-27 |
1972-09-19 |
Richardson Merrell Inc |
Treating viral infections with bis-basic ethers and thioethers of fluorenone and fluorene and pharmaceutical compositons of the same
|
|
US3917624A
(en)
|
1972-09-27 |
1975-11-04 |
Pfizer |
Process for producing 2-amino-nicotinonitrile intermediates
|
|
US4006237A
(en)
*
|
1973-10-11 |
1977-02-01 |
Beecham Group Limited |
Tetrahydrocarbostyril derivatives for the prophylaxis of asthma, hayfever and rhinitis
|
|
US3891660A
(en)
|
1974-02-07 |
1975-06-24 |
Squibb & Sons Inc |
Derivatives of 1H-imidazo{8 4,5-c{9 pyridine-7-carboxylic acids and esters
|
|
US3899508A
(en)
|
1974-04-12 |
1975-08-12 |
Lilly Co Eli |
5-(2-Aminophenyl)pyrazole-3-carboxylic acids and esters thereof
|
|
DE2423389A1
(de)
|
1974-05-14 |
1975-12-04 |
Hoechst Ag |
Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung
|
|
US4381344A
(en)
*
|
1980-04-25 |
1983-04-26 |
Burroughs Wellcome Co. |
Process for producing deoxyribosides using bacterial phosphorylase
|
|
DE3204126A1
(de)
|
1982-02-06 |
1983-08-11 |
Bayer Ag, 5090 Leverkusen |
Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
US4758574A
(en)
|
1982-05-03 |
1988-07-19 |
Eli Lilly And Company |
2-phenylimidazio (4,5-c) pyridines
|
|
US4563525A
(en)
*
|
1983-05-31 |
1986-01-07 |
Ici Americas Inc. |
Process for preparing pyrazolopyridine compounds
|
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
CA1271477A
(en)
|
1983-11-18 |
1990-07-10 |
John F. Gerster |
1h-imidazo[4,5-c]quinolin-4-amines
|
|
ZA848968B
(en)
|
1983-11-18 |
1986-06-25 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
|
|
JPS61112075A
(ja)
|
1984-11-05 |
1986-05-30 |
Shionogi & Co Ltd |
チエニルピラゾロキノリン誘導体
|
|
US4668686A
(en)
|
1985-04-25 |
1987-05-26 |
Bristol-Myers Company |
Imidazoquinoline antithrombrogenic cardiotonic agents
|
|
US4593821A
(en)
|
1985-04-25 |
1986-06-10 |
Laros Equipment Company, Inc. |
Belt separator for blow molding parts
|
|
US4698346A
(en)
|
1985-05-08 |
1987-10-06 |
Usv Pharmaceutical Corporation |
Thiazolo[5,4-h]quinoline compounds useful as anti-allergy agents
|
|
US4826830A
(en)
|
1985-07-31 |
1989-05-02 |
Jui Han |
Topical application of glyciphosphoramide
|
|
CA1306260C
(en)
|
1985-10-18 |
1992-08-11 |
Shionogi & Co., Ltd. |
Condensed imidazopyridine derivatives
|
|
HU197019B
(en)
*
|
1985-11-12 |
1989-02-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing thiqzolo (4,5-c) quinoline derivatives and pharmaceuticals comprising same
|
|
US4837378A
(en)
|
1986-01-15 |
1989-06-06 |
Curatek Pharmaceuticals, Inc. |
Topical metronidazole formulations and therapeutic uses thereof
|
|
US4775674A
(en)
|
1986-05-23 |
1988-10-04 |
Bristol-Myers Company |
Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
|
|
CA1287061C
(en)
*
|
1986-06-27 |
1991-07-30 |
Roche Holding Ltd. |
Pyridine ethanolamine derivatives
|
|
US5500228A
(en)
*
|
1987-05-26 |
1996-03-19 |
American Cyanamid Company |
Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease
|
|
US4880779A
(en)
|
1987-07-31 |
1989-11-14 |
Research Corporation Technologies, Inc. |
Method of prevention or treatment of AIDS by inhibition of human immunodeficiency virus
|
|
US4774339A
(en)
|
1987-08-10 |
1988-09-27 |
Molecular Probes, Inc. |
Chemically reactive dipyrrometheneboron difluoride dyes
|
|
US5536743A
(en)
|
1988-01-15 |
1996-07-16 |
Curatek Pharmaceuticals Limited Partnership |
Intravaginal treatment of vaginal infections with buffered metronidazole compositions
|
|
US5225183A
(en)
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
US5736553A
(en)
*
|
1988-12-15 |
1998-04-07 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
|
|
US5756747A
(en)
|
1989-02-27 |
1998-05-26 |
Riker Laboratories, Inc. |
1H-imidazo 4,5-c!quinolin-4-amines
|
|
DK0385630T3
(da)
|
1989-02-27 |
1997-05-12 |
Riker Laboratories Inc |
1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler
|
|
US5457183A
(en)
|
1989-03-06 |
1995-10-10 |
Board Of Regents, The University Of Texas System |
Hydroxylated texaphyrins
|
|
US5037986A
(en)
|
1989-03-23 |
1991-08-06 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
NZ232740A
(en)
|
1989-04-20 |
1992-06-25 |
Riker Laboratories Inc |
Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
|
|
US4988815A
(en)
*
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
|
US5750134A
(en)
|
1989-11-03 |
1998-05-12 |
Riker Laboratories, Inc. |
Bioadhesive composition and patch
|
|
CA2071897A1
(en)
|
1989-12-28 |
1991-06-29 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
|
US5274113A
(en)
|
1991-11-01 |
1993-12-28 |
Molecular Probes, Inc. |
Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
|
|
BR9106391A
(pt)
|
1990-04-30 |
1993-04-27 |
Isis Pharmaceuticals Inc |
Oligonucleotideo ou analogo de oligonucleotideo,processo para modular o metaboslismo do acido araquidonico em um animal,e,processo para tratar um anumal suspeito de ter uma doenca que e modulada por mudancas na sintese ou no metabolismo do acido arquidonico
|
|
EP0461040A1
(fr)
|
1990-06-08 |
1991-12-11 |
Roussel Uclaf |
Dérivés de l'imidazole, leur procédé de préparation, les intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
|
|
EP0553202B1
(en)
|
1990-10-05 |
1995-04-12 |
Minnesota Mining And Manufacturing Company |
Process for the preparation of imidazo[4,5-c]quinolin-4-amines
|
|
MX9203481A
(es)
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
|
US5248782A
(en)
|
1990-12-18 |
1993-09-28 |
Molecular Probes, Inc. |
Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5175296A
(en)
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
|
US5342784A
(en)
|
1991-04-12 |
1994-08-30 |
Mitsubishi Paper Mills Limited |
Electrophotographic lithographic printing plate
|
|
JPH04327587A
(ja)
|
1991-04-26 |
1992-11-17 |
Asahi Chem Ind Co Ltd |
６’−ｃ−アルキル−３−デアザネプラノシンａ誘導体、その製造法およびその用途
|
|
US5187288A
(en)
*
|
1991-05-22 |
1993-02-16 |
Molecular Probes, Inc. |
Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
|
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
TW300219B
(enExample)
|
1991-09-14 |
1997-03-11 |
Hoechst Ag |
|
|
PH31245A
(en)
|
1991-10-30 |
1998-06-18 |
Janssen Pharmaceutica Nv |
1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
|
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
|
US5378848A
(en)
*
|
1992-02-12 |
1995-01-03 |
Shionogi & Co., Ltd. |
Condensed imidazopyridine derivatives
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
EP0641192B1
(en)
|
1992-05-18 |
1997-07-23 |
Minnesota Mining And Manufacturing Company |
Transmucosal drug delivery device
|
|
US5352680A
(en)
|
1992-07-15 |
1994-10-04 |
Regents Of The University Of Minnesota |
Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
|
|
US6608201B2
(en)
|
1992-08-28 |
2003-08-19 |
3M Innovative Properties Company |
Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5395937A
(en)
*
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
US5569450A
(en)
|
1993-03-17 |
1996-10-29 |
Minnesota Mining And Manufacturing Company |
Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
|
|
DE4309969A1
(de)
|
1993-03-26 |
1994-09-29 |
Bayer Ag |
Substituierte heteroanellierte Imidazole
|
|
EP0622681B1
(en)
|
1993-04-27 |
1997-10-01 |
Agfa-Gevaert N.V. |
Process for incorporation of a water-insoluble substance into a hydrophilic layer
|
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
CZ288182B6
(en)
*
|
1993-07-15 |
2001-05-16 |
Minnesota Mining & Mfg |
Imidazo[4,5-c]pyridine-4-amines and pharmaceutical preparations based thereon
|
|
US5648516A
(en)
*
|
1994-07-20 |
1997-07-15 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
CA2131680C
(en)
|
1993-09-17 |
2006-11-07 |
Gerhard Stucky |
Process for preparing imidazopyridine derivatives
|
|
US5837809A
(en)
|
1995-08-11 |
1998-11-17 |
Oregon Health Sciences University |
Mammalian opioid receptor ligand and uses
|
|
JPH07163368A
(ja)
*
|
1993-12-15 |
1995-06-27 |
Hayashibara Biochem Lab Inc |
組換えｄｎａとその組換えｄｎａを含む形質転換体
|
|
TW574214B
(en)
|
1994-06-08 |
2004-02-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
EP1167378B1
(en)
*
|
1994-07-15 |
2011-05-11 |
University of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5612377A
(en)
*
|
1994-08-04 |
1997-03-18 |
Minnesota Mining And Manufacturing Company |
Method of inhibiting leukotriene biosynthesis
|
|
US5644063A
(en)
|
1994-09-08 |
1997-07-01 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]pyridin-4-amine intermediates
|
|
GB9420168D0
(en)
|
1994-10-06 |
1994-11-23 |
Boots Co Plc |
Therapeutic agents
|
|
US5571819A
(en)
|
1994-11-22 |
1996-11-05 |
Sabb; Annmarie L. |
Imidazopyridines as muscarinic agents
|
|
US5482936A
(en)
*
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
|
US6071949A
(en)
|
1995-03-14 |
2000-06-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
|
|
US5585612A
(en)
|
1995-03-20 |
1996-12-17 |
Harp Enterprises, Inc. |
Method and apparatus for voting
|
|
FR2732605B1
(fr)
|
1995-04-07 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Composition destinee a l'induction d'une reponse immunitaire mucosale
|
|
US5766789A
(en)
|
1995-09-29 |
1998-06-16 |
Energetics Systems Corporation |
Electrical energy devices
|
|
EP0778277B1
(en)
|
1995-12-08 |
2003-06-25 |
Pfizer Inc. |
Substituted heterocyclic derivatives as CRF antagonists
|
|
US5939047A
(en)
|
1996-04-16 |
1999-08-17 |
Jernberg; Gary R. |
Local delivery of chemotherapeutic agents for treatment of periodontal disease
|
|
US5861268A
(en)
*
|
1996-05-23 |
1999-01-19 |
Biomide Investment Limited Partnership |
Method for induction of tumor cell apoptosis with chemical inhibitors targeted to 12-lipoxygenase
|
|
DE19621241C2
(de)
*
|
1996-05-25 |
2000-03-16 |
Manfred Kessler |
Membranelektrode zur Messung der Glucosekonzentration in Flüssigkeiten
|
|
US5693811A
(en)
|
1996-06-21 |
1997-12-02 |
Minnesota Mining And Manufacturing Company |
Process for preparing tetrahdroimidazoquinolinamines
|
|
US5741908A
(en)
*
|
1996-06-21 |
1998-04-21 |
Minnesota Mining And Manufacturing Company |
Process for reparing imidazoquinolinamines
|
|
WO1998001448A1
(en)
*
|
1996-07-03 |
1998-01-15 |
Japan Energy Corporation |
Novel purine derivatives
|
|
US6387938B1
(en)
|
1996-07-05 |
2002-05-14 |
Mochida Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
|
US6039969A
(en)
*
|
1996-10-25 |
2000-03-21 |
3M Innovative Properties Company |
Immune response modifier compounds for treatment of TH2 mediated and related diseases
|
|
US5939090A
(en)
|
1996-12-03 |
1999-08-17 |
3M Innovative Properties Company |
Gel formulations for topical drug delivery
|
|
JP4101302B2
(ja)
|
1997-01-09 |
2008-06-18 |
テルモ株式会社 |
新規アミド誘導体および合成中間体
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6426334B1
(en)
|
1997-04-30 |
2002-07-30 |
Hybridon, Inc. |
Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
|
|
US6303347B1
(en)
|
1997-05-08 |
2001-10-16 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
EP1003531B1
(en)
*
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Processes for preparing nucleic acid constructs
|
|
US6123957A
(en)
|
1997-07-16 |
2000-09-26 |
Jernberg; Gary R. |
Delivery of agents and method for regeneration of periodontal tissues
|
|
US6077349A
(en)
|
1997-08-20 |
2000-06-20 |
Sony Corporation |
Method and apparatus for manufacturing disc-shaped recording medium
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
DE69817393T2
(de)
|
1997-11-28 |
2004-06-17 |
Sumitomo Pharmaceuticals Co., Ltd. |
Neue heterozyklische verbindungen
|
|
US6121323A
(en)
|
1997-12-03 |
2000-09-19 |
3M Innovative Properties Company |
Bishydroxyureas
|
|
UA67760C2
(uk)
|
1997-12-11 |
2004-07-15 |
Міннесота Майнінг Енд Мануфакчурінг Компані |
Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
|
|
TW572758B
(en)
*
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
|
GB9804377D0
(en)
|
1998-03-03 |
1998-04-22 |
Speights Limited |
Lighting device
|
|
US6114058A
(en)
|
1998-05-26 |
2000-09-05 |
Siemens Westinghouse Power Corporation |
Iron aluminide alloy container for solid oxide fuel cells
|
|
US6110929A
(en)
*
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
|
JP2000119271A
(ja)
*
|
1998-08-12 |
2000-04-25 |
Hokuriku Seiyaku Co Ltd |
１ｈ―イミダゾピリジン誘導体
|
|
US5962636A
(en)
|
1998-08-12 |
1999-10-05 |
Amgen Canada Inc. |
Peptides capable of modulating inflammatory heart disease
|
|
US6518280B2
(en)
*
|
1998-12-11 |
2003-02-11 |
3M Innovative Properties Company |
Imidazonaphthyridines
|
|
US6486168B1
(en)
|
1999-01-08 |
2002-11-26 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
|
HU229441B1
(en)
|
1999-01-08 |
2013-12-30 |
3M Innovative Properties Co |
Formulations and methods for treating mucosal associated conditions with an immune response modifier
|
|
US20020058674A1
(en)
*
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
|
EP1495758A3
(en)
|
1999-01-08 |
2005-04-13 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
|
US6558951B1
(en)
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
|
US6294271B1
(en)
|
1999-02-12 |
2001-09-25 |
Shin-Etsu Chemical Co., Ltd. |
Flip-chip type semiconductor device sealing material and flip-chip type semiconductor device
|
|
JP2000247884A
(ja)
|
1999-03-01 |
2000-09-12 |
Sumitomo Pharmaceut Co Ltd |
アラキドン酸誘発皮膚疾患治療剤
|
|
JP2002541810A
(ja)
|
1999-04-12 |
2002-12-10 |
レキシコン ジェネティックス インコーポレーテッド |
新規リポキシゲナーゼタンパク質およびそれをコードするポリヌクレオチド
|
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
US6451810B1
(en)
|
1999-06-10 |
2002-09-17 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
|
US6541485B1
(en)
*
|
1999-06-10 |
2003-04-01 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
|
US6756382B2
(en)
|
1999-06-10 |
2004-06-29 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
|
US6573273B1
(en)
|
1999-06-10 |
2003-06-03 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
|
US6315985B1
(en)
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
|
MXPA02001610A
(es)
|
1999-08-13 |
2003-07-21 |
Hybridon Inc |
Modulacion de estimulacion inmune mediada por oligonucleotido cpg mediante la modificacion posicional de nucleosidos.
|
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
|
EP1223915B1
(en)
*
|
1999-10-29 |
2005-12-21 |
Nektar Therapeutics |
Dry powder compositions having improved dispersivity
|
|
US6916925B1
(en)
|
1999-11-05 |
2005-07-12 |
3M Innovative Properties Co. |
Dye labeled imidazoquinoline compounds
|
|
US6376669B1
(en)
*
|
1999-11-05 |
2002-04-23 |
3M Innovative Properties Company |
Dye labeled imidazoquinoline compounds
|
|
US6313156B1
(en)
|
1999-12-23 |
2001-11-06 |
Icos Corporation |
Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
|
|
US20040023870A1
(en)
*
|
2000-01-21 |
2004-02-05 |
Douglas Dedera |
Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
|
|
GB0001704D0
(en)
*
|
2000-01-25 |
2000-03-15 |
Glaxo Group Ltd |
Protein
|
|
CN1422269A
(zh)
|
2000-02-09 |
2003-06-04 |
北陆制药株式会社 |
1h－咪唑并吡啶衍生物
|
|
US6649172B2
(en)
|
2000-03-17 |
2003-11-18 |
Corixa Corporation |
Amphipathic aldehydes and their uses as adjuvants and immunoeffectors
|
|
US20010046968A1
(en)
|
2000-03-23 |
2001-11-29 |
Zagon Ian S. |
Opioid growth factor modulates angiogenesis
|
|
CN1203073C
(zh)
|
2000-03-30 |
2005-05-25 |
盐野义制药株式会社 |
稠合咪唑并吡啶衍生物的生产方法和晶体形式
|
|
US6894060B2
(en)
*
|
2000-03-30 |
2005-05-17 |
3M Innovative Properties Company |
Method for the treatment of dermal lesions caused by envenomation
|
|
US20020137101A1
(en)
|
2000-05-19 |
2002-09-26 |
Meyers Rachel A. |
46638, a novel human lipoxygenase family member and uses thereof
|
|
DE10020465A1
(de)
|
2000-04-26 |
2001-11-08 |
Osram Opto Semiconductors Gmbh |
Strahlungsemittierendes Halbleiterbauelement mit Lumineszenzkonversionselement
|
|
DE10029580C1
(de)
*
|
2000-06-15 |
2002-01-10 |
Ferton Holding Sa |
Vorrichtung zum Entfernen von Körpersteinen mit einem intrakorporalen Lithotripter
|
|
US6387383B1
(en)
|
2000-08-03 |
2002-05-14 |
Dow Pharmaceutical Sciences |
Topical low-viscosity gel composition
|
|
US6900016B1
(en)
|
2000-09-08 |
2005-05-31 |
Applera Corporation |
Polymorphisms in known genes associated with inflammatory autoimmune disease, methods of detection and uses thereof
|
|
CA2419894A1
(en)
|
2000-09-15 |
2002-03-21 |
Coley Pharmaceutical Gmbh |
Process for high throughput screening of cpg-based immuno-agonist/antagonist
|
|
US20020055517A1
(en)
|
2000-09-15 |
2002-05-09 |
3M Innovative Properties Company |
Methods for delaying recurrence of herpes virus symptoms
|
|
GB0023008D0
(en)
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
JPWO2002046479A1
(ja)
*
|
2000-12-07 |
2004-04-08 |
株式会社青山製作所 |
鋼材部品のベイキング処理方法
|
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
AU2002232498B2
(en)
*
|
2000-12-08 |
2006-05-04 |
3M Innovative Properties Company |
Screening method for identifying compounds that selectively induce interferon alpha
|
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
US6677348B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
|
UA74593C2
(en)
|
2000-12-08 |
2006-01-16 |
3M Innovative Properties Co |
Substituted imidazopyridines
|
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US6677347B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
|
UA75622C2
(en)
*
|
2000-12-08 |
2006-05-15 |
3M Innovative Properties Co |
Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
|
|
US6664260B2
(en)
*
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
|
US6525064B1
(en)
*
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US20060142202A1
(en)
|
2000-12-08 |
2006-06-29 |
3M Innovative Properties Company |
Compositions and methods for targeted delivery of immune response modifiers
|
|
KR100455713B1
(ko)
|
2001-01-29 |
2004-11-06 |
호남석유화학 주식회사 |
올레핀 중합용 다중핵 메탈로센 촉매 및 이를 이용한중합방법
|
|
US20020182274A1
(en)
*
|
2001-03-21 |
2002-12-05 |
Kung-Ming Lu |
Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
|
|
WO2002085905A1
(en)
|
2001-04-17 |
2002-10-31 |
Sumitomo Pharmaceuticals Company, Limited |
Novel adenine derivatives
|
|
WO2002085933A1
(en)
*
|
2001-04-20 |
2002-10-31 |
The Institute For Systems Biology |
Toll-like receptor 5 ligands and methods of use
|
|
US20020193729A1
(en)
|
2001-04-20 |
2002-12-19 |
Cormier Michel J.N. |
Microprojection array immunization patch and method
|
|
US6627639B2
(en)
|
2001-04-26 |
2003-09-30 |
Wyeth |
Uses for indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino-[2,3-e]indole
|
|
EP1401437A1
(en)
|
2001-06-15 |
2004-03-31 |
3M Innovative Properties Company |
Immune response modifiers for the treatment of periodontal disease
|
|
US7226928B2
(en)
|
2001-06-15 |
2007-06-05 |
3M Innovative Properties Company |
Methods for the treatment of periodontal disease
|
|
US6756399B2
(en)
|
2001-06-29 |
2004-06-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents
|
|
EP1408041A4
(en)
|
2001-07-16 |
2005-08-17 |
Shionogi & Co |
PROCESS FOR THE PREPARATION OF AMIDINE DERIVATIVES
|
|
EP1427445A4
(en)
|
2001-08-30 |
2006-09-06 |
3M Innovative Properties Co |
METHODS OF MATURING PLASMOCYTOID DENDRITIC CELLS USING MOLECULES MODIFYING IMMUNE RESPONSES
|
|
EP1434579B1
(en)
|
2001-10-09 |
2011-06-08 |
Amgen Inc. |
Imidazole derivatives as antiinflammatory agents
|
|
EP1478371A4
(en)
|
2001-10-12 |
2007-11-07 |
Univ Iowa Res Found |
METHOD AND PRODUCTS FOR IMPROVING IMMUNE RESPONSES WITH IMIDAZOCHINOLINE COMPOUNDS
|
|
EP1719511B1
(en)
|
2001-11-16 |
2008-12-10 |
3M Innovative Properties Company |
N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
|
|
EP1455789A4
(en)
*
|
2001-11-17 |
2008-02-13 |
Martinez Colon Maria |
IMIQUIMOD THERAPIES
|
|
DE60234376D1
(de)
|
2001-11-27 |
2009-12-24 |
Anadys Pharmaceuticals Inc |
3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimin-nucleoside und ihre verwendung
|
|
AU2002363954B2
(en)
|
2001-11-29 |
2008-04-03 |
3M Innovative Properties Company |
Pharmaceutical formulations comprising an immune response modifier
|
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
US6775514B2
(en)
|
2002-01-11 |
2004-08-10 |
Xerox Corporation |
Substrate size monitoring system for use in copier/printers
|
|
US6525028B1
(en)
*
|
2002-02-04 |
2003-02-25 |
Corixa Corporation |
Immunoeffector compounds
|
|
US20050281813A1
(en)
|
2002-02-14 |
2005-12-22 |
Nuvelo, Inc. |
Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
|
|
US7030129B2
(en)
|
2002-02-22 |
2006-04-18 |
3M Innovative Properties Company |
Method of reducing and treating UVB-induced immunosuppression
|
|
PT1487485E
(pt)
*
|
2002-03-19 |
2011-03-11 |
Powderject Res Ltd |
Adjuvantes de imidazoquinolina para vacinas de adn
|
|
US20030185835A1
(en)
|
2002-03-19 |
2003-10-02 |
Braun Ralph P. |
Adjuvant for vaccines
|
|
EP3006043B1
(en)
|
2002-04-04 |
2019-05-29 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
|
JP4723239B2
(ja)
|
2002-04-30 |
2011-07-13 |
ユニジェン・インコーポレーテッド |
治療剤としての遊離−ｂ−環フラボノイド類とフラバン類との混合物の製剤
|
|
GB0211649D0
(en)
|
2002-05-21 |
2002-07-03 |
Novartis Ag |
Organic compounds
|
|
AU2003233519A1
(en)
|
2002-05-29 |
2003-12-19 |
3M Innovative Properties Company |
Process for imidazo(4,5-c)pyridin-4-amines
|
|
BR0311648A
(pt)
|
2002-06-07 |
2005-04-19 |
3M Innovative Properties Co |
Imidazopiridinas substituìdas por éter
|
|
HRP20050159A2
(en)
*
|
2002-07-23 |
2005-08-31 |
Teva Gy�gyszergy�r R�szv�nyt�rsas�g |
Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via 1h-imidazo [4,5-c]quinolin-4-ph-thalimide intermediates
|
|
ATE357445T1
(de)
*
|
2002-07-26 |
2007-04-15 |
Teva Gyogyszergyar Zartkoeruee |
Darstellung von 1h-imidazo(4,5-c)chinolin-4- aminen über neue 1h-imidazo(4,5-c)chinolin-4- cyano- und 1h-imidazo(4,5-c)chinolin-4-carboxamid intermediate
|
|
ES2355819T3
(es)
|
2002-08-15 |
2011-03-31 |
3M Innovative Properties Company |
Composiciones inmunoestimuladoras y métodos para estimular una respuesta inmune.
|
|
JP2006503068A
(ja)
|
2002-09-26 |
2006-01-26 |
スリーエム イノベイティブ プロパティズ カンパニー |
１ｈ−イミダゾダイマー
|
|
AU2003270701B2
(en)
|
2002-10-31 |
2009-11-12 |
Amgen Inc. |
Antiinflammation agents
|
|
AU2003294249A1
(en)
|
2002-11-08 |
2004-06-03 |
Trimeris, Inc. |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
AU2003287316A1
(en)
|
2002-12-11 |
2004-06-30 |
3M Innovative Properties Company |
Assays relating to toll-like receptor activity
|
|
WO2004053057A2
(en)
|
2002-12-11 |
2004-06-24 |
3M Innovative Properties Company |
Gene expression systems and recombinant cell lines
|
|
CA2510375A1
(en)
*
|
2002-12-20 |
2004-07-15 |
3M Innovative Properties Company |
Aryl / hetaryl substituted imidazoquinolines
|
|
EP1578419A4
(en)
|
2002-12-30 |
2008-11-12 |
3M Innovative Properties Co |
IMMUNOSTIMULATING COMBINATIONS
|
|
US7375180B2
(en)
|
2003-02-13 |
2008-05-20 |
3M Innovative Properties Company |
Methods and compositions related to IRM compounds and Toll-like receptor 8
|
|
WO2004075865A2
(en)
|
2003-02-27 |
2004-09-10 |
3M Innovative Properties Company |
Selective modulation of tlr-mediated biological activity
|
|
JP2006519866A
(ja)
|
2003-03-04 |
2006-08-31 |
スリーエム イノベイティブ プロパティズ カンパニー |
Ｕｖ誘発性の表皮の新形成の予防的治療
|
|
US7163947B2
(en)
*
|
2003-03-07 |
2007-01-16 |
3M Innovative Properties Company |
1-Amino 1H-imidazoquinolines
|
|
MXPA05009488A
(es)
|
2003-03-07 |
2005-12-14 |
3M Innovative Properties Co |
1-amino 1h-imidazoquinolinas.
|
|
EP1603510B1
(en)
|
2003-03-13 |
2012-05-09 |
3M Innovative Properties Company |
Methods of improving skin quality
|
|
US7699057B2
(en)
|
2003-03-13 |
2010-04-20 |
3M Innovative Properties Company |
Methods for treating skin lesions
|
|
AU2004220465A1
(en)
*
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Method of tattoo removal
|
|
JP2006523452A
(ja)
|
2003-03-25 |
2006-10-19 |
スリーエム イノベイティブ プロパティズ カンパニー |
共通のＴｏｌｌ様受容体を通じて媒介される細胞活性の選択的活性化
|
|
US20040192585A1
(en)
|
2003-03-25 |
2004-09-30 |
3M Innovative Properties Company |
Treatment for basal cell carcinoma
|
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
|
WO2004091500A2
(en)
|
2003-04-10 |
2004-10-28 |
3M Innovative Properties Company |
Delivery of immune response modifier compounds
|
|
US20040265351A1
(en)
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
|
US20040214851A1
(en)
|
2003-04-28 |
2004-10-28 |
3M Innovative Properties Company |
Compositions and methods for induction of opioid receptors
|
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
|
US6943255B2
(en)
|
2003-06-06 |
2005-09-13 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
|
WO2004110992A2
(en)
|
2003-06-06 |
2004-12-23 |
3M Innovative Properties Company |
Process for imidazo[4,5-c] pyridin-4-amines
|
|
BRPI0411514A
(pt)
|
2003-06-20 |
2006-08-01 |
Coley Pharm Gmbh |
antagonistas de receptor toll-like de molécula pequena
|
|
MY157827A
(en)
|
2003-06-27 |
2016-07-29 |
3M Innovative Properties Co |
Sulfonamide substituted imidazoquinolines
|
|
US20050106300A1
(en)
|
2003-06-30 |
2005-05-19 |
Purdue Research Foundation |
Method for producing a material having an increased solubility in alcohol
|
|
EP1651185A1
(en)
*
|
2003-07-31 |
2006-05-03 |
3M Innovative Properties Company |
Bioactive compositions comprising triazines
|
|
CN1852711A
(zh)
*
|
2003-08-05 |
2006-10-25 |
3M创新有限公司 |
使用免疫响应调节化合物的传染病预防
|
|
AU2004266658A1
(en)
*
|
2003-08-12 |
2005-03-03 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazo-containing compounds
|
|
PL1653959T3
(pl)
|
2003-08-14 |
2015-10-30 |
3M Innovative Properties Co |
Modyfikatory odpowiedzi immunologicznej modyfikowane lipidami
|
|
US20050048072A1
(en)
*
|
2003-08-25 |
2005-03-03 |
3M Innovative Properties Company |
Immunostimulatory combinations and treatments
|
|
US8961477B2
(en)
|
2003-08-25 |
2015-02-24 |
3M Innovative Properties Company |
Delivery of immune response modifier compounds
|
|
RU2006105101A
(ru)
|
2003-08-27 |
2007-10-10 |
3М Инновейтив Пропертиз Компани (US) |
Арилокси и арилалкиленокси замещенные имидазохинолины
|
|
US20060216333A1
(en)
|
2003-09-02 |
2006-09-28 |
Miller Richard L |
Methods related to the treatment of mucosal associated conditions
|
|
EA200600540A1
(ru)
*
|
2003-09-05 |
2006-08-25 |
Анадис Фармасьютикалз, Инк. |
Введение лигандов tlr7 и их пролекарств для лечения инфекции вируса гепатита с
|
|
AU2004270201A1
(en)
|
2003-09-05 |
2005-03-17 |
3M Innovative Properties Company |
Treatment for CD5+ B cell lymphoma
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
EP1664342A4
(en)
|
2003-09-17 |
2007-12-26 |
3M Innovative Properties Co |
SELECTIVE MODULATION OF TLR GENE EXPRESSION
|
|
WO2005033049A2
(en)
|
2003-10-01 |
2005-04-14 |
Taro Pharmaceuticals U.S.A., Inc. |
METHOD OF PREPARING 4-AMINO-1H-IMIDAZO(4,5-c)QUINOLINES AND ACID ADDITION SALTS THEREOF
|
|
RU2412942C2
(ru)
*
|
2003-10-03 |
2011-02-27 |
3М Инновейтив Пропертиз Компани |
Оксизамещенные имидазохинолины, способные модулировать биосинтез цитокинов
|
|
US20090075980A1
(en)
*
|
2003-10-03 |
2009-03-19 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and Analogs Thereof
|
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
|
CA2543685A1
(en)
|
2003-10-31 |
2005-05-12 |
3M Innovative Properties Company |
Neutrophil activation by immune response modifier compounds
|
|
US20050239733A1
(en)
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
|
ITMI20032121A1
(it)
|
2003-11-04 |
2005-05-05 |
Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm |
Procedimento per la preparazione di imiquimod e suoi intermedi
|
|
EP1685129A4
(en)
*
|
2003-11-14 |
2008-10-22 |
3M Innovative Properties Co |
OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
|
|
WO2005048945A2
(en)
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazo ring compounds
|
|
CU23404A1
(es)
|
2003-11-19 |
2009-08-04 |
Ct Ingenieria Genetica Biotech |
Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes
|
|
AR046845A1
(es)
|
2003-11-21 |
2005-12-28 |
Novartis Ag |
Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
|
|
BRPI0416801A
(pt)
|
2003-11-21 |
2007-01-09 |
Novartis Ag |
derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
|
|
CA2547020C
(en)
*
|
2003-11-25 |
2014-03-25 |
3M Innovative Properties Company |
1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
|
|
WO2005051324A2
(en)
|
2003-11-25 |
2005-06-09 |
3M Innovative Properties Company |
Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
|
|
US8940755B2
(en)
|
2003-12-02 |
2015-01-27 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
|
US20050226878A1
(en)
|
2003-12-02 |
2005-10-13 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
|
WO2005076783A2
(en)
|
2003-12-04 |
2005-08-25 |
3M Innovative Properties Company |
Sulfone substituted imidazo ring ethers
|
|
JP2007517035A
(ja)
*
|
2003-12-29 |
2007-06-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
|
|
WO2005066172A1
(en)
|
2003-12-29 |
2005-07-21 |
3M Innovative Properties Company |
Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
|
|
JP2007517055A
(ja)
|
2003-12-30 |
2007-06-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答の増強
|
|
US20050158325A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Immunomodulatory combinations
|
|
CA2551399A1
(en)
*
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
|
JP4991520B2
(ja)
|
2004-03-15 |
2012-08-01 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答調節剤製剤および方法
|
|
TW200612932A
(en)
|
2004-03-24 |
2006-05-01 |
3M Innovative Properties Co |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
|
WO2005110013A2
(en)
|
2004-04-09 |
2005-11-24 |
3M Innovative Properties Company |
Methods, compositions, and preparations for delivery of immune response modifiers
|
|
BRPI0510430A
(pt)
*
|
2004-04-28 |
2007-10-30 |
3M Innovative Properties Co |
composições e métodos para vacinação mucosal
|
|
US20050267145A1
(en)
|
2004-05-28 |
2005-12-01 |
Merrill Bryon A |
Treatment for lung cancer
|
|
US20080015184A1
(en)
*
|
2004-06-14 |
2008-01-17 |
3M Innovative Properties Company |
Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines
|
|
WO2005123080A2
(en)
|
2004-06-15 |
2005-12-29 |
3M Innovative Properties Company |
Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
|
US20070259881A1
(en)
|
2004-06-18 |
2007-11-08 |
Dellaria Joseph F Jr |
Substituted Imidazo Ring Systems and Methods
|
|
WO2006009826A1
(en)
|
2004-06-18 |
2006-01-26 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
|
AU2005283085B2
(en)
*
|
2004-06-18 |
2012-06-21 |
3M Innovative Properties Company |
Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
|
|
WO2006093514A2
(en)
|
2004-06-18 |
2006-09-08 |
3M Innovative Properties Company |
Aryl and arylalkylenyl substituted thiazoloquinolines and thiazolonaphthyridines
|
|
WO2006065280A2
(en)
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
|
|
US7897609B2
(en)
|
2004-06-18 |
2011-03-01 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
|
WO2006026470A2
(en)
*
|
2004-08-27 |
2006-03-09 |
3M Innovative Properties Company |
Hiv immunostimulatory compositions
|
|
WO2006026394A2
(en)
*
|
2004-08-27 |
2006-03-09 |
3M Innovative Properties Company |
Method of eliciting an immune response against hiv
|
|
WO2006026760A2
(en)
|
2004-09-02 |
2006-03-09 |
3M Innovative Properties Company |
1-amino imidazo-containing compounds and methods
|
|
WO2006028962A2
(en)
|
2004-09-02 |
2006-03-16 |
3M Innovative Properties Company |
1-alkoxy 1h-imidazo ring systems and methods
|
|
WO2006029115A2
(en)
*
|
2004-09-02 |
2006-03-16 |
3M Innovative Properties Company |
2-amino 1h imidazo ring systems and methods
|
|
WO2006029223A2
(en)
|
2004-09-08 |
2006-03-16 |
Children's Medical Center Corporation |
Method for stimulating the immune response of newborns
|
|
CN101824034A
(zh)
|
2004-09-14 |
2010-09-08 |
诺华疫苗和诊断公司 |
咪唑并喹啉化合物
|
|
EP1804583A4
(en)
|
2004-10-08 |
2009-05-20 |
3M Innovative Properties Co |
ADJUVANT FOR DNA VACCINE
|
|
US20100113565A1
(en)
|
2004-12-08 |
2010-05-06 |
Gorden Keith B |
Immunostimulatory combinations and methods
|
|
WO2006063072A2
(en)
|
2004-12-08 |
2006-06-15 |
3M Innovative Properties Company |
Immunomodulatory compositions, combinations and methods
|
|
US8080560B2
(en)
*
|
2004-12-17 |
2011-12-20 |
3M Innovative Properties Company |
Immune response modifier formulations containing oleic acid and methods
|
|
SI1830876T1
(sl)
*
|
2004-12-30 |
2015-08-31 |
Meda Ab |
Uporaba imikvimoda za zdravljenje kožnih metastaz, ki izhajajo iz rakavega tumorja dojke
|
|
US20080119508A1
(en)
|
2004-12-30 |
2008-05-22 |
3M Innovative Properties Company |
Multi-Route Administration Of Immune Response Modifier Compounds
|
|
US8436176B2
(en)
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
|
NZ556399A
(en)
|
2004-12-30 |
2009-03-31 |
Takeda Pharmaceutical |
1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine methanesulfonate
|
|
CA2592904C
(en)
|
2004-12-30 |
2015-04-07 |
3M Innovative Properties Company |
Chiral fused [1,2]imidazo[4,5-c] ring compounds
|
|
EP1831221B1
(en)
|
2004-12-30 |
2012-08-08 |
3M Innovative Properties Company |
Substituted chiral fused 1,2 imidazo 4,5-c ring compounds
|
|
ATE545010T1
(de)
|
2005-02-02 |
2012-02-15 |
Mocon Inc |
Instrument und verfahren zum detektieren und melden der grösse von lecks in hermetisch abgedichteten verpackungen
|
|
EP1844201B1
(en)
|
2005-02-04 |
2016-08-24 |
3M Innovative Properties Company |
Aqueous gel formulations containing immune response modifiers
|
|
WO2006086449A2
(en)
|
2005-02-09 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
|
|
AU2006338521A1
(en)
|
2005-02-09 |
2007-10-11 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
|
|
CA2597587A1
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
|
|
AU2006216997A1
(en)
|
2005-02-11 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Substituted imidazoquinolines and imidazonaphthyridines
|
|
CA2597595A1
(en)
*
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods
|
|
EP1851220A2
(en)
|
2005-02-23 |
2007-11-07 |
3M Innovative Properties Company |
Hydroxyalkyl substituted imidazonaphthyridines
|
|
WO2006091567A2
(en)
|
2005-02-23 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Hydroxyalkyl substituted imidazoquinoline compounds and methods
|
|
US8178677B2
(en)
*
|
2005-02-23 |
2012-05-15 |
3M Innovative Properties Company |
Hydroxyalkyl substituted imidazoquinolines
|
|
WO2006091647A2
(en)
|
2005-02-23 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Method of preferentially inducing the biosynthesis of interferon
|
|
CA2602098A1
(en)
|
2005-03-14 |
2006-09-21 |
Graceway Pharmaceuticals, Llc |
Method of treating actinic keratosis
|
|
EP1863770A4
(en)
|
2005-04-01 |
2010-05-05 |
Coley Pharm Group Inc |
RING CLOSURE AND CORRESPONDING METHODS AND INTERMEDIATE PRODUCTS
|
|
EP1863813A2
(en)
*
|
2005-04-01 |
2007-12-12 |
Coley Pharmaceutical Group, Inc. |
Pyrazolo[3,4-c]quinolines, pyrazolo[3,4-c]naphthyridines, analogs thereof, and methods
|
|
CA2602590A1
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
|
AU2006232377A1
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
|
CA2605808A1
(en)
|
2005-04-25 |
2006-11-02 |
3M Innovative Properties Company |
Immunostimulatory compositions
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
JP4584335B2
(ja)
|
2005-09-02 |
2010-11-17 |
ファイザー・インク |
ヒドロキシ置換１ｈ−イミダゾピリジンおよび方法
|
|
EA200800782A1
(ru)
|
2005-09-09 |
2008-08-29 |
Коли Фармасьютикал Груп, Инк. |
ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ
|
|
ZA200803029B
(en)
|
2005-09-09 |
2009-02-25 |
Coley Pharm Group Inc |
Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
|
|
US8889154B2
(en)
|
2005-09-15 |
2014-11-18 |
Medicis Pharmaceutical Corporation |
Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
|
|
CA2623541A1
(en)
|
2005-09-23 |
2007-03-29 |
Coley Pharmaceutical Group, Inc. |
Method for 1h-imidazo[4,5-c]pyridines and analogs thereof
|
|
EP1948173B1
(en)
|
2005-11-04 |
2013-07-17 |
3M Innovative Properties Company |
Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
|
|
WO2007062043A1
(en)
|
2005-11-23 |
2007-05-31 |
Coley Pharmaceutical Group Inc. |
Method of activating murine toll-like receptor 8
|
|
CA2634017A1
(en)
|
2005-12-16 |
2007-07-05 |
Coley Pharmaceutical Group, Inc. |
Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods
|
|
WO2007079086A1
(en)
|
2005-12-28 |
2007-07-12 |
Coley Pharmaceutical Group, Inc. |
Pyrazoloalkyl substituted imidazo ring compounds and methods
|
|
WO2007079171A2
(en)
|
2005-12-28 |
2007-07-12 |
Coley Pharmaceutical Group, Inc. |
Treatment for hodgkin's lymphoma
|
|
WO2007079202A2
(en)
|
2005-12-28 |
2007-07-12 |
Coley Pharmaceutical Group, Inc. |
Treatment for acute lymhoblastic leukemia
|
|
WO2007079169A2
(en)
|
2005-12-28 |
2007-07-12 |
Coley Pharmaceutical Group, Inc. |
Treatment for acute myeloid leukemia
|
|
WO2007079146A1
(en)
|
2005-12-28 |
2007-07-12 |
Coley Pharmaceutical Group, Inc |
Treatment for non-hodgkin's lymphoma
|
|
US20090246174A1
(en)
|
2005-12-28 |
2009-10-01 |
Rook Alain H |
Treatment for cutaneous t cell lymphoma
|
|
WO2007092641A2
(en)
|
2006-02-10 |
2007-08-16 |
Coley Pharmaceutical Group, Inc. |
Method for substituted 1h-imidazo[4,5-c]pyridines
|
|
EP3085373A1
(en)
*
|
2006-02-22 |
2016-10-26 |
3M Innovative Properties Company |
Immune response modifier conjugates
|
|
WO2007106852A2
(en)
|
2006-03-15 |
2007-09-20 |
Coley Pharmaceutical Group, Inc. |
Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods
|
|
US8329721B2
(en)
|
2006-03-15 |
2012-12-11 |
3M Innovative Properties Company |
Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
|
|
WO2007143526A2
(en)
|
2006-06-05 |
2007-12-13 |
Coley Pharmaceutical Group, Inc. |
Substituted tetrahydroimidazonaphthyridines and methods
|
|
WO2007149802A2
(en)
*
|
2006-06-19 |
2007-12-27 |
3M Innovative Properties Company |
Formulation for delivery of immune response modifiers
|
|
US7906506B2
(en)
*
|
2006-07-12 |
2011-03-15 |
3M Innovative Properties Company |
Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
|
|
CA2659733A1
(en)
*
|
2006-07-31 |
2008-02-07 |
3M Innovative Properties Company |
Sterilized topical compositions of 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine
|
|
US8178539B2
(en)
|
2006-09-06 |
2012-05-15 |
3M Innovative Properties Company |
Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
|
|
WO2008036312A1
(en)
|
2006-09-19 |
2008-03-27 |
Coley Pharmaceutical Group, Inc. |
Fungicidal methods using immune response modifier compounds
|
|
WO2008045543A1
(en)
|
2006-10-13 |
2008-04-17 |
Coley Pharmaceutical Group, Inc. |
Substituted 4h-imidazo [4, 5, 1-ij] [1, 6] naphthyridine-9-amines and their pharmaceutical use
|
|
US20080149123A1
(en)
|
2006-12-22 |
2008-06-26 |
Mckay William D |
Particulate material dispensing hairbrush with combination bristles
|